Genetic Counselors + Hereditary Cancer

Up to 35% of colorectal cancer patients have at least one family member with colorectal cancer.

Approx. 5-10% of colorectal cancers are caused by an inherited genetic condition. 

Genetic counselors are on the front lines for hereditary cancer detection, and can be key to your care team.

Before, or even after, a cancer diagnosis, genetic counselors help evaluate your family history to understand your risk for an inherited cancer syndrome related to colorectal and other types of cancer. After evaluating this risk, they can recommend genetic testing options and then help interpret those results.

If a hereditary cancer syndrome is identified during genetic testing, genetic counselors work alongside your care team to guide you through important next steps.

  1. Education about cancer prevention and management, including
    • lifestyle modifications like diet and exercise.
    • appropriate cancer screenings.
    • other medical interventions are necessary to prevent cancer.
  2. Collaborate to provide comprehensive cancer care and help integrate genetic information into patient care. 
  3. Find and provide emotional support and resources to help patients and families cope with the emotional impact of genetic information and cancer risk. 
  4. Assisting with appropriate genetic testing for direct family members who may also be at risk for the same hereditary cancer syndrome.

Common CRC-related Hereditary Cancer Syndromes

Lynch Syndrome (Hereditary Non-Polyposis Colorectal Cancer or HNPCC)

Lynch syndrome is associated with a genetic predisposition for colon and many other types of cancer. An estimated 1 in 279 Americans have Lynch syndrome, but most are unaware.

Lynch syndrome is an autosomal dominant condition, meaning a person only needs to inherit the gene from one parent to be affected. Talk to a genetic counselor about being screened for Lynch syndrome if you have a strong family history of Lynch-related cancers in first degree (parent, siblings, and children) and second degree (aunts, uncles, grandparents, etc.) relatives on the same side of the family tree.

Lynch-related cancers include colorectal cancer, endometrial cancer, ovarian cancer, stomach cancer, small bowel cancer, ureter or renal pelvis cancer, bladder cancer, bile duct cancer, pancreatic cancer, or sebaceous adenomas of the skin.

Persons with Lynch syndrome should be screened for colorectal cancer with colonoscopy every year and have several other cancer screenings annually.

More about Lynch syndrome

Familial Adenomatous Polyposis (FAP)

FAP is an inherited cancer condition resulting in the growth of hundreds to thousands of polyps in the colon and rectum. If untreated, this condition is associated with a nearly 100% lifetime risk of colorectal cancer. Many patients with FAP choose to remove their colon to prevent colorectal cancer from developing.

FAP is a rare disease. Estimated to affect about 1 in 8,000 people and about 0.5% of all colorectal cancer cases. A FAP diagnosis will be made if a patient has at least 100 polyps and an APC mutation found during genetic testing.

Like Lynch syndrome, FAP is an autosomal dominant condition. Patients with a first-degree relative with FAP or a personal history of numerous polyps (more than 10 cumulative colorectal adenomas) should be screened for FAP.

The average age for colon polyps associated with FAP begins is 16.  Families with a known FAP condition should start colorectal cancer screening with colonoscopy as early as age 10.

MUTYH-Associated Polyposis (MAP)

MAP is an autosomal recessive condition caused by inheriting mutations of the MUTYH gene from both parents. The MUTYH is crucial for repairing DNA during normal cell renewal. If the condition is inherited from only one parent, that person is considered a carrier.

This condition causes less than 1% of all colon cancers, but by age 60 more than half of people with MAP will develop colon cancer.  Without colonoscopy screening to remove polyps and monitor colon health, more than 80% of people with MAP could develop colorectal cancer during their lifetime.

Talk to a genetic counselor about testing for MAP if you have a personal history of 10 or more colorectal adenomas by age 60, 20 or more colorectal adenomas at any age, 5+ sessile serrated polyps in the first half of the colon, OR a family history of MAP or a large number of polyps.

MAP is an extremely rare condition, affecting approximately 1 in 20,000 to 40,000 people. People with a known MAP diagnosis should begin colorectal cancer screening with a colonoscopy between the ages 25 and 30.

Familial Colorectal Cancer Type X (FCCTX)

FCCTX may be considered a subtype of Lynch syndrome, but while Lynch syndrome tumors show microsatellite instability (MSI), FCCTX tumors are microsatellite stable (MSS). (see biomarkers page for more)

The cause for FCCTX is still unknown, and research is ongoing.

If you have a strong family history with no other known genetic syndrome, talk to a genetic counselor about your risks, whether genetic testing is appropriate, and if earlier colonoscopy screening is needed.

Families with a strong history of colorectal cancer are recommended to begin colonoscopy screening 5 to 10 years before the earliest onset case, with additional colonoscopies every 3 to 5 years after.

Frequently Asked Questions

Why is genetic testing important?

  • Genetic testing is used to identify individuals at risk for colorectal and other cancers due to inherited genetic mutations.
  • Science is continually evolving, and some hereditary colorectal cancer-associated genes are not yet known.
  • Not everyone with a genetic mutation will develop cancer.

Who should have genetic testing?

  • If multiple family members have the same type of cancer or related cancers.
  • If there are colorectal cancer diagnoses in multiple generations of the same family.
  • A family member diagnosed with early-onset cancer (under age 50).
  • Note: not all people with a family history of colorectal cancer will need genetic testing.

How does CRC screening change for those with a family history or a genetic CRC syndrome?

  • If you have a first degree relative with colorectal cancer, screening should begin approximately 10 years before the youngest CRC diagnosis.
  • Individuals with a genetic syndrome may need more frequent or earlier colon cancer screenings.
  • Colonoscopy is the only appropriate colorectal cancer screening method for those with family history or a genetic syndrome.

What CRC prevention and treatment is available for those with genetic syndromes?

  • With regular surveillance patients with a genetic syndrome can live long healthy lives.
  • For some, preventive measures like prophylactic surgery may be taken to prevent cancer.
  • Appropriate colorectal cancer treatment based on the genetic syndrome and cancer-specific biomarkers can have significant impact on cancer treatments and outcomes.

Not all people with a family history of colorectal cancer will need genetic testing. If you think you may be at risk, talk to your doctor or a genetic counselor. Early knowledge can lead to life-saving prevention and personalized care.